Survival Outcomes of Ovarian Malignancies in Chinese Population
Sponsor
Lei Li (Other)
Overall Status
Recruiting
CT.gov ID
NCT03291262
Collaborator
(none)
5,000
1
72
69.5
Study Details
Study Description
Brief Summary
This study aims to determine survival outcomes (overall survival and progression-free survival) of primary ovarian malignancies in China and relevant risk factors in a prospective cohort study.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Survival Outcomes of Ovarian Malignancies in Chinese Population
Actual Study Start Date
:
Jan 1, 2017
Anticipated Primary Completion Date
:
Jan 1, 2022
Anticipated Study Completion Date
:
Jan 1, 2023
Outcome Measures
Primary Outcome Measures
- Overall survival [5 years]
Periods from diagnosis of ovarian cancer to death
- Progression-free survival [5 years]
Periods from diagnosis of ovarian cancer or remission of disease to next recurrence
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Primary ovarian malignancies.
Exclusion Criteria:
- Metastatic malignancies to ovaries.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Lei Li | Beijing | China/Beiing | China | 100000 |
Sponsors and Collaborators
- Lei Li
Investigators
- Principal Investigator: Lei Li, MD, Peking Union Medical College Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Lei Li,
Professor,
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT03291262
Other Study ID Numbers:
- SOOM-1
First Posted:
Sep 25, 2017
Last Update Posted:
Nov 14, 2018
Last Verified:
Nov 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: